In particular, SNHG5 upregulates GSK3β by competitively binding miR-26a-5p in HCC, thereby aberrantly activating Wnt/β-catenin signaling and inducing EMT, which contributes to invasion and metastasis [32]. This evidence concerns the gene SNHG5 and hepatocellular carcinoma.